The Asia-Pacific Region’s Growing Role in Oncology Trials

Presented by

Premier Research

About this talk

The Asia-Pacific region is seeing rapid growth in oncology drug research, with a 138 percent increase in clinical trial activity from 2010 to 2020, according to a recent Clinical Trials Arena report. The APAC region now ranks first in the world for the number of ongoing oncology clinical trials, accounting for more than half of those studies. Large populations, a favorable regulatory climate, and a high incidence of cancer are among the many reasons sponsors are drawn to the region. In this webinar, we will examine the advantages of conducting trials in this fast-growing region and explore other issues sponsors should consider when choosing sites for upcoming trials. Topics include: - Patient access - Cost advantages - Regulatory landscape - The digital revolution Key Learning Objectives: - Recognize the advantages of the patient population in APAC - Understand the APAC regulatory landscape - Learn how APAC is positioned to adopt new technologies Presenters: Rupa Doshi, Ph.D., Vice President, Oncology Strategy, Premier Research Eleanor Guest, Senior Director, Clinical Operations, Premier Research Alice Wang, Associate Director, Regulatory Affairs, Premier Consulting

Related topics:

More from this channel

Upcoming talks (1)
On-demand talks (77)
Subscribers (3192)
Premier Research is a clinical research company, dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.